Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-02-01 @ 5:52 AM
Study NCT ID:
NCT02046850
Status:
COMPLETED
Last Update Posted:
2014-04-29
First Post:
2014-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers
Sponsor:
AstraZeneca
Organization: